US Congress urged to ‘close gaps’ in global drug supply chains

A US group has issued a warning that Congress must act to plug vulnerabilities in global pharmaceutical supply chains that potentially allow sub-standard or dangerous products to reach patients.

This entry was posted in cat-news. Bookmark the permalink.

Comments are closed.